Preliminary report: effects of interleukin-1 on platelet counts
- PMID: 1975894
- DOI: 10.1016/0140-6736(90)92206-w
Preliminary report: effects of interleukin-1 on platelet counts
Retraction in
-
Retraction: effects of interleukin-1 on platelet counts.Lancet. 1992 Aug 22;340(8817):496. doi: 10.1016/0140-6736(92)91827-u. Lancet. 1992. PMID: 1354831 No abstract available.
Abstract
Recombinant human interleukin-1 beta was given in 5 daily intravenous infusions to ten patients with metastatic malignant disorders as part of an antineoplastic trial. All ten patients experienced transient increases in heart rate, low-grade fevers, and rigors. A neutrophil-dominated 100% rise in leucocyte counts occurred 4-8 h after treatment. Leucocyte counts returned to baseline levels within 24 h of interleukin-1 beta infusion. A 50% rise in platelets occurred in response to interleukin-1 beta; the increase in platelet counts was first noted 6 days after treatment began and was sustained for 24 days after treatment. Interleukin-1 beta may therefore be beneficial in the treatment of conditions of thrombocytopenia associated with haematological disorders and chemotherapy for malignant disorders.
Comment in
-
Haematological effects of interleukin-1.Lancet. 1990 Dec 15;336(8729):1506. doi: 10.1016/0140-6736(90)93210-g. Lancet. 1990. PMID: 1979111 No abstract available.
-
Final findings of scientific misconduct.NIH Guide Grants Contracts (Bethesda). 1994 Aug 12;23(30):2. NIH Guide Grants Contracts (Bethesda). 1994. PMID: 8031608 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
